SYMBIOMIX

Serial Number 88282091
606

Registration Progress

Application Filed
Jan 30, 2019
Under Examination
Oct 3, 2023
Approved for Publication
Aug 8, 2023
Published for Opposition
Aug 8, 2023
Registered

Trademark Image

SYMBIOMIX

Basic Information

Serial Number
88282091
Filing Date
January 30, 2019
Published for Opposition
August 8, 2023
Abandonment Date
May 6, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 6, 2024
Classes
005

Rights Holder

LUPIN INC.

03
Address
5801 PELICAN BAY BLVD
SUITE 500
NAPLES, FL 34108

Ownership History

Symbiomix Therapeutics, LLC

Original Applicant
16
Newark, NJ

LUPIN INC.

New Owner Before Publication #1
03
NAPLES, FL

LUPIN INC.

Owner at Publication
03
NAPLES, FL

Legal Representation

Attorney
Robert L. Powley

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

28 events
Date Code Type Description Documents
May 6, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 6, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 3, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 8, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 8, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 19, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 3, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 28, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Dec 13, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
May 9, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Apr 1, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 13, 2021 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Mar 17, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 12, 2020 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
May 11, 2020 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Apr 29, 2020 ALIE A ASSIGNED TO LIE Loading...
Oct 15, 2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Oct 15, 2019 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Oct 15, 2019 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 11, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 11, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 11, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 12, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 12, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 12, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 11, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 22, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 2, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical and biological preparations used for the treatment of women's health infections, disorders, and diseases, specifically for the treatment of bacterial vaginosis, gynecologic infections, sexually transmitted diseases, breast cancer, ovarian and cervical cancer, and bone density disorders

Classification

International Classes
005